Targets for human micro rnas in avian influenza virus (h5n1) genome

{
  "publication_number": "US2008045472A1",
  "country": "US",
  "kind": "A1",
  "title": "Targets for human micro rnas in avian influenza virus (h5n1) genome",
  "abstract": "The present invention relates to targets for Human microRNAs in Avian Influenza Virus (H5N1) Genome and provides specific miRNA targets against H5N1 virus. Existing therapies for Avian flu are of limited use primarily due to genetic re-assortment of the viral genome, generating novel proteins, and thus escaping immune response. In animal models, baculovirus-derived recombinant H5 vaccines were immunogenic and protective, but results in humans were disappointing even when using high doses. Currently, two classes of drugs are available with antiviral activity against influenza viruses: inhibitors of the M2 ion channel, amantadine and rimantadine, and inhibitors of neuraminidase, oseltamivir, and zanamivir. There is paucity of information regarding effectiveness of these drugs in H5N1 infection. These drugs are also well known to have side effects like neurotoxicity. Thus there exists a need to develop alternate therapy for targeting the Avian flu virus (H5N1). The present invention addresses this need in the field.",
  "claims": [
    "1. An avian flu virus strain H5N1 genomic target for a human microRNA, comprising a polynucleotide having a nucleotide sequence that is selected from SEQ ID NO:1 and SEQ ID NO:2. 2. The H5N1 genomic target of claim 1 wherein the human microRNA is selected from the group consisting of has-miR-136 [SEQ ID NO:6] and has-miR-507 [SEQ ID NO:5]. 3. The H5N1 genomic target of claim 1 which is a target of the human microRNA has-miR-507 having the sequence set forth in SEQ ID NO:5, wherein the target is in a H5N1 PB2 gene and comprises the nucleotide sequence set forth in SEQ ID NO:1. 4. The H5N1 genomic target of claim 1 which is a target of the human microRNA has-miR-1 36 having the sequence set forth in SEQ ID NO:6, wherein the target is in a H5N1 HA gene and comprises the nucleotide sequence set forth in SEQ ID NO:2. 5. A method for identifying a genomic target nucleotide sequence for a human microRNA in an avian flu virus strain H5N1 genome nucleotide reference sequence, comprising: (a) computationally shuffling the avian flu virus strain H5N1 genome nucleotide reference sequence with sequence-shuffling software to obtain one or more shuffled avian flu virus strain H5N1 genome nucleotide reference sequences; (b) deriving a cut-off score by running one or more microRNA target prediction software programs selected from miRanda, RNAhybrid, MicroInspector and DianaMicroT, to computationally predict one or more complementary target sequences for one or a plurality of human microRNA sequences in the shuffled avian flu virus strain H5N1 genome nucleotide reference sequences of (a) to obtain for each human microRNA sequence a first value which is said cut-off score; (c) determining a second value for each of one or more target sequences in the avian flu virus strain H5N1 genome nucleotide reference sequence that are complementary to said one or a plurality of human microRNA sequences by running one or more of the microRNA target prediction software programs selected from miRanda, RNAhybrid, MicroInspector and DianaMicroT, to computationally predict one or more complementary target sequences for the human microRNA sequences in the avian flu virus strain H5N1 genome nucleotide reference sequences to obtain therefrom said second value; (d) selecting one or more complementary target sequences in the avian flu virus strain H5N1 genome nucleotide reference sequence from step (c) for which the second value is greater than the cut-off score of step (b) to obtain a set of consensus predicted complementary microRNA-H5N1 genome target pairs; and (e) computationally mapping each consensus predicted microRNA-H5N1 genome target pair of (d) to the avian flu virus strain H5N1 genome nucleotide reference sequence, and therefrom identifying a genomic target nucleotide sequence for a human microRNA in the avian flu virus strain H5N1 genome nucleotide reference sequence. 6. The method of claim 5 wherein in step (e) the microRNA-H5N1 genome target pair is computationally mapped to a target sequence in the H5N1 genome that is selected from SEQ ID NO:1 and SEQ ID NO:2. 7. The method of claim 5 wherein the sequence-shuffling software in step (a) comprises an EMBOSS2 ShuffleSeq program that performs a seed stretch to computationally shuffle the avian flu virus strain H5N1 genome nucleotide reference sequence. 8. The method of claim 5 wherein step (b) comprises running miRanda, RNAhybrid, MicroInspector and DianaMicroT microRNA target prediction software programs that are based on experimentally derived rules of miRNA-mRNA interaction. 9. The method of claim 5 wherein steps (b) and (c) each comprise running the miRanda microRNA target prediction software program. 10. The method of claim 5 wherein computational prediction of targets comprises one or more of prediction of target sequence complementarity with a microRNA sequence, prediction of minimum free energy of a microRNA-H5N1 genome target pair duplex, and prediction of continuous seed complimentarity toward a 5′ end of the microRNA. 11. A method for determining progression of an avian flu infection, comprising detecting a human miRNA level wherein the miRNA is complementary to an avian flu virus strain H5N1 genome nucleotide sequence. 12. A method for preventing avian flu virus H5N1/A infection or inhibiting avian flu virus H5N1/A disease progression, comprising administering a composition comprising a microRNA that is selected from the group consisting of has-miR-507 (SEQ ID NO:5) and has-mir-136 (SEQ ID NO:6), or a homologue thereof, wherein the composition inhibits H5N1/A viral protein synthesis. 13. An avian flu virus strain H5N1 genome-derived polynucleotide that comprises a target for a human microRNA, comprising: a genomic target nucleotide sequence for a human microRNA in an avian flu virus strain H5N1 genome that is identified according to the method of claim 5."
  ],
  "description_excerpt": "1.Field of the Invention\n\nThe present invention relates to the targets for human microRNAs in Avian Influenza Virus (H5N1) Genome. The invention particularly provides specific miRNA targets against H5N1 virus.\n\n2.Description of the Related Art\n\nThe 186 cases (as of March 2006, WHO report) of Avian influenza caused by H5N1 virus in humans with increasing reports of cases in poultry and migratory birds, has created great concern and panic globally. Influenza virus has the capability to re-assort its genetic material thereby giving rise to novel antigenic proteins which can defy the immune response mechanism. These influenza viruses occur naturally among birds. Wild birds worldwide carry the viruses in their intestines, but are usually not affected by them. However, avian influenza is very contagious among birds and can make some domesticated birds, including chickens, ducks, and turkeys etc. very sick and kill them.\n\nInfected birds shed influenza virus in their saliva, nasal secretions, and feces. Susceptible birds become infected when they have contact with contaminated secretions or excretions or with surfaces that are contaminated with secretions or excretions from infected birds. Domesticated birds may become infected with avian influenza virus through direct contact with infected waterfowl or other infected poultry, or through contact with surfaces (such as dirt or cages and droppings) or materials (such as water or feed) that have been contaminated with the virus.\n\nInfection with avian influenza viruses in domestic poultry causes two main forms of disease that are distinguished by low and high extremes of virulence.",
  "cpc": [
    "C07K 14/005",
    "A61P 31/16",
    "C12N 15/1131",
    "C12N 2310/14",
    "C12N 2330/10",
    "C12N 2760/16122",
    "C12Q 1/6897",
    "G01N 2333/11",
    "G01N 2500/00",
    "G16B 20/00",
    "G16B 20/20",
    "G16B 30/00"
  ],
  "ipc": [
    "A61K 31/711",
    "A61P 31/16",
    "C12N 15/113",
    "G01N 33/50",
    "G06G 7/48",
    "G16B 20/20",
    "G16B 30/00"
  ],
  "assignees": [
    "Council of Scientific and Industrial Research CSIR"
  ],
  "inventors": [
    "Samir Brahmachari",
    "Manoj Hariharan",
    "Vinod Scaria",
    "Beena Pillai"
  ],
  "filing_date": "2007-03-29",
  "publication_date": "2008-02-21",
  "priority_date": "2006-03-31",
  "application_number": "US-69361107-A",
  "family_id": "39102092",
  "cited_by_count": 22,
  "citations": [
    "US5225326A",
    "US5525470A"
  ]
}